Navigation Links
Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Date:11/6/2007

(R) technology. These molecules and compounds could be currently available or are in pre-clinical or clinical development. Such molecules or compounds usually cannot be delivered by the oral route of administration or the benefits of these compounds are limited due to poor bioavailability, slow on-set of action or variable absorption. The eligen(R) technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, per rectum, pulmonary, intra-vaginal or transdermal. The Web site is: http://www.emisphere.com.

Safe Harbor Statement Regarding Forward-Looking Statements

The statements in this release and oral statements made by representatives of Emisphere relating to matters that are not historical facts (including without limitation those regarding future performance or financial results, the timing or potential outcomes of research collaborations or clinical trials, any market that might develop for any of Emisphere's product candidates and the sufficiency of Emisphere's cash and other capital resources) are forward-looking statements that involve risks and uncertainties, including, but not limited to, the likelihood that actual performance or results could materially differ, that future research will prove successful, the likelihood that any product in the research pipeline will receive regulatory approval in the United States or abroad, the ability of Emisphere and/or its partners to develop, manufacture and commercialize products using Emisphere's drug delivery technology, or Emisphere's ability to fund such efforts with or without partners. Emisphere undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly any forward-looking statements should be read in conjunction with the additional risks and uncertainties detaile
'/>"/>

SOURCE Emisphere Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
3. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
4. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014   Mast Therapeutics, Inc. (NYSE ... that Santosh Vetticaden, Chief Medical Officer and Senior ... personal reasons, in mid-September.  Edwin L. Parsley ... Pharmaceuticals, which Mast acquired earlier this year, will ... interim Chief Medical Officer.  Dr. Parsley previously was ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "China Orthopedic Instrument Industry Report, 2014-2017" report to ... population and rising proportion of reimbursement for medical expenses, ... released, with its scale presenting a CAGR of 19.2% ... are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... Does your doctor know what you,re smoking?  Chances ... marijuana to the over 112,000 currently registered patients under ... the other roughly 20,300+ active physicians listed with the Colorado ... – even though a poll in February 2014 showed 51% ... tried it. "With marijuana legalization underway, every ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... Colo. , May 10 Heska Corporation (Nasdaq: HSKA ) today ... Wednesday, May 12, 2010 .  The presentation will be at The Intercontinental Hotel ... and is scheduled to begin at 9:55 a.m. Eastern Time . , ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) , ...
... May 10 Dr. Richard Hays ... diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled ... Phase III studies testing the safety and efficacy of an ... has completed enrollment of more than 530 subjects with type ...
Cached Medicine Technology:Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes 2
(Date:8/29/2014)... The Department of Health and Human Services (HHS) ... today allowing healthcare providers to attest for Meaningful Use ... (CEHRT) or a combination of the 2011 and 2014 ... able to fully implement 2014 Edition CEHRT for a ... use 2011 Edition CEHRT, or a combination of 2011/2014 ...
(Date:8/29/2014)... Los Angeles, CA (PRWEB) August 29, 2014 ... has announced his plan to rename his practice to ... US Hair Restoration has served the needs of hair ... clients who traveled to its centers in Los Angeles, ... results through surgical and non surgical treatments, many of ...
(Date:8/29/2014)... 30, 2014 UWDress.com, one of the ... its latest collection of 2014 floor length bridesmaid ... for these wonderful items. According to the company’s marketing ... a greatly discounted rate (up to 60 percent off) ... products has a special neckline: strapless, one-shoulder, bateau and ...
(Date:8/29/2014)... 2014 As reported by GantDaily.com in the ... Abuse Trends , Outbreaks (8/20), the National Institute on Drug ... drug abuse trends by turning to social media. As NIDA ... it is also working with the University of Maryland to ... Warning System, which will be funded by the National Institute ...
(Date:8/29/2014)... Dallas, Texas (PRWEB) August 30, 2014 ... Glass microfiber Industry, 2009-2019 is a professional and ... microfiber industry. The report firstly reviews the basic ... and manufacturing technology. The report then explores global ... their product specification, capacity, Production value, and market ...
Breaking Medicine News(10 mins):Health News:Quirk Healthcare Outlook on MU2 Delay Confirmation 2Health News:US Hair Restoration Changes Name to Parsa Mohebi Hair Restoration to Better Reflect Founder 2Health News:2014 Floor Length Bridesmaid Dresses for Sale at UWDress.com 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4
... Based on findings of a recent study researchers say eating ... Researchers say they have found a correlation between high consumption ... hot dogs, and lunch meats like ham, salami and bologna, ... study, nearly 149,000 meat eaters between ages 50 and 74 ...
... part of the body’s immune system and help protect ... A new study shows promising treatment for acute myelogenous ... natural killer cells from a patient’s family member. ... the highly fatal cancer of the bone marrow that ...
... study researchers say autistic boys with language problems might have ... disorder known as Specific Language Impairment (SLI) // and they ... and how to choose the best treatments for individual components ... at Broca’s area -- a key language center in the ...
... as a man’s disease, but recent reports suggest it ... is helping to identify which women are at highest ... records of nearly 2,400 women taking part in the ... heart disease are about three-times more likely to develop ...
... New research shows that people who have implanted ... safely use magnetic resonance imaging .// ,Pacemakers ... regulate an abnormal heartbeat known as arrhythmia. Researchers ... of the MRI may heat up metal components ...
... gene known as “mighty mouse” might be beneficial in ... a German neurologist , stumbled // on a newborn who ... child had a mutation in his myostatin gene that effectively ... known to regulate muscle growth. So far the child, now ...
Cached Medicine News:
... Plate is a semi-rigid system intended ... The Slim-LOC is based on the ... current market technology. The Slim-LOC system ... instrumentation. Reduced width (16 mm), low ...
... is an Anterior Cervical Plating System ... flexibility and simplicity for the spinal ... function and safe fixation of the ... meet the needs of the spinal ...
... is intended for supportive stabilization of ... fusion. The device utilizes bi-cortical fixation ... is enhanced through dynamic screw holes ... single level interbody fusion. Anterior cervical ...
... designed to meet the clinical challenges of ... locking mechanism and the choice of fixed ... angle screws for ease of implantation in ... system allows the surgeon the versatility of ...
Medicine Products: